Company intelligence / Profile preview

ViaCord

Cambridge, Massachusetts, United Statesviacord.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

ViaCord has over 30 years of experience in cord blood and tissue banking. It has released over 500 units for transplant or research use in conditions like autism and cerebral palsy. The company is accredited by AABB and CLIA/FDA registered. It offers unique services such as DNA/genetic health insights using banked samples. Nearly 600 families have used their stored units in clinical settings.

Therapeutic areas: Metabolic DisordersImmunologyNeurologyHematology
Modalities: Hematopoietic stem cells (HSCs) from cord bloodMesenchymal stem cells (MSCs) from cord tissueGenomic/DNA testing
Industry: Molecular Diagnostics

Partnerships

Collaborated with Brigham and Women’s Hospital, The Christ Hospital Cincinnati, University of Cincinnati Hoxworth Blood Center during development phase

Beyond the preview

Go deeper on ViaCord.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViaCord.

Explore the full profile